We need to be able to respond instantly to the sickest patients rolling into the resus bay–sometimes with no warning at all.
The man, the myth, the legend–Farkas unleashed
Mind of the Resuscitationist Episode on Functional Heuristics
A different take on IV T3 for Myxedema
The RECOVERY trial just released a preprint demonstrating benefit from tocilizumab in COVID-19. As with the prior RECOVERY studies, this is a multicenter, open-label, pragmatic trial. A robust mortality benefit was detected (the fragility index calculates to 17, which isn’t too shabby). Several important secondary endpoints were positive as well (e.g., reduced intubation rate, reduced […]